European Healthtech startup funding raised during Q4 2021.
In Q4 2021, 182 European Healthtech companies raised a combined €2.9B across 183 funding rounds, up 96.1% versus Q4 2020. France led by capital raised, and BGF was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Sotio Biotech | Other | Dec 2021 | €280M |
| Owkin | Other | Nov 2021 | €159M |
| Sword Health | Series D+ | Nov 2021 | €145M |
| DNA Script | Series C | Oct 2021 |
14 exits · €1.2B disclosed.
| BenevolentAI | IPO | Dec 2021 | €435M |
| Current Health | Acquisition | Nov 2021 | €357M |
| Sanifit | Acquisition | Nov 2021 | €205M |
| Bicycle Therapeutics | IPO | Oct 2021 | €173M |
| Infinite Leap | Acquisition | Nov 2021 | €27M |
| Inositec | Acquisition | Nov 2021 | €19M |
| €142M |
| Quell Therapeutics | Series B | Nov 2021 | €138M |
| DentalMonitoring | Other | Oct 2021 | €129M |
| MindMaze | Other | Oct 2021 | €108M |
| Anaveon | Series B | Dec 2021 | €105M |
| bit.bio | Series B | Nov 2021 | €89M |
| Emergence Therapeutics | Other | Dec 2021 | €87M |
| Northsea Therapeutics | Other | Dec 2021 | €71M |
| IOmx Therapeutics | Series B | Oct 2021 | €65M |
| ViCentra | Series C | Dec 2021 | €65M |
| Lifen | Series C | Nov 2021 | €50M |
| Ieso | Series B | Nov 2021 | €47M |
